Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

sciatica/necrose

O link é salvo na área de transferência
Página 1 a partir de 69 resultados
METHODS Triple blind randomized controlled study. OBJECTIVE To establish the treatment effect of etanercept in acute sciatica secondary to lumbar disc herniation. BACKGROUND Etanercept is a selective competitor of tumor necrosis factor-alpha which is a proinflammatory cytokine. It is currently used
BACKGROUND The aim of this study was to assess the efficacy and safety of tumor necrosis factor (TNF)-α inhibition with infliximab (IFX) in treating recurrent and disabling chronic sciatica pain associated with post-operative peridural lumbar fibrosis. METHODS A double-blind, placebo-controlled
METHODS The possibility to prevent nucleus pulposus-induced functional and structural nerve root injury by selective tumor necrosis factor-alpha inhibition was assessed in an experimental model in the pig spine. OBJECTIVE The objective of the study was to evaluate the role of tumor necrosis
METHODS Prospective randomized trial. OBJECTIVE To examine the effect of the tumor necrosis factor alpha (TNF-α) inhibitor, etanercept, on radicular pain by its epidural administration onto spinal nerves in patients with lumbar spinal stenosis. BACKGROUND TNF-α is thought to play a crucial role in

Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
METHODS An open-label study was conducted. OBJECTIVE To evaluate the efficacy and safety of infliximab, a monoclonal chimeric antibody, against tumor necrosis factor-alpha (TNFalpha) for the treatment of severe sciatica. BACKGROUND Evidence from animal studies indicates that TNFalpha plays a role in

A systematic review and meta-analysis of biological treatments targeting tumour necrosis factor α for sciatica.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE Systematic review comparing biological agents, targeting tumour necrosis factor α, for sciatica with placebo and alternative interventions. METHODS We searched 21 electronic databases and bibliographies of included studies. We included randomised controlled trials (RCTs), non-RCTs and
OBJECTIVE Currently, no satisfactory treatment is available for sciatica caused by herniated discs and/or spinal stenosis. The objective of this study is to assess the value of tumor necrosis factor (TNF)-α inhibitors in the treatment of sciatica. METHODS Without language restrictions, we searched

[Efficacy of tumor necrosis factor-alpha blockade for severe sciatica?].

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The domain of sciatica is at the edge of a mini revolution. For ten years evidence have been accumulating in favour of a local inflammation rather than a pathology resulling only from a nerve compression. This hypothesis has first been strengthened by the discovery of inflammatory mediators in human

[Sciatica as a sign of hip disorder with a review of the diagnosis of aseptic necrosis of the femoral head].

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se

Can sciatica induced by disc herniation be treated with tumor necrosis factor alpha blockade?

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE We identified several problems associated with percutaneous lumbar disc decompression (PLDD) based on a study of patients who required salvage operations for complications after undergoing PLDD at an outside institution. BACKGROUND PLDD has been performed as a new treatment for

Inflammatory biomarkers in patients with sciatica: a systematic review.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
This systematic review focusses on inflammation as an underlying pathogenic mechanism in sciatica. We addressed two questions in particular: (1) what inflammatory biomarkers have been identified in patients with sciatica in the literature so far? 2) is there an association between the

A Comparison of the Efficacy and Tolerability of the Treatments for Sciatica: A Network Meta-Analysis.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND There remains a lack of a systematic summary of the efficacy and safety of various medicines for sciatica, and discrepancies among these exist. OBJECTIVE The aim of this study is to comprehensively assess the efficacy of and tolerance to several medical options for the treatment of
Junte-se à nossa
página do facebook

O mais completo banco de dados de ervas medicinais apoiado pela ciência

  • Funciona em 55 idiomas
  • Curas herbais apoiadas pela ciência
  • Reconhecimento de ervas por imagem
  • Mapa GPS interativo - marcar ervas no local (em breve)
  • Leia publicações científicas relacionadas à sua pesquisa
  • Pesquise ervas medicinais por seus efeitos
  • Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas

Google Play badgeApp Store badge